The New York Stock Exchange ended the session with Pfizer jumping 2.23% to $41.24 on Monday while the New York Stock Exchange slid 0.43% to $14,355.00.

Pfizer today’s close was $41.24, 0.41% below its 52-week high of $41.41.

News about Pfizer today

Pfizer, astra shots to be combined in u.k. Covid vaccine trials. According to today’s article on Bloomberg Quint, “Even as it begins the first Covid immunizations with a shot from Pfizer Inc., the U.K. plans to test it in combination with another vaccine from AstraZeneca Plc.”

Pfizer’s Sales

Pfizer’s sales growth is a negative 9.7% for the current quarter and a decline by 9.1% for the next. The company’s growth estimates for the present quarter and the next is a negative 9.1% and a negative 11.3%, respectively.

Pfizer’s Revenue

Year-on-year quarterly revenue growth declined by 4.3%, now sitting on 48.65B for the twelve trailing months.

Pfizer’s Stock Top and Bottom Yearly Value

Pfizer’s stock is valued at $41.24 at 21:05 EST, below its 52-week high of $41.41 and way higher than its 52-week low of $26.45.

Pfizer’s Moving Average

Pfizer’s worth is way higher than its 50-day moving average of $36.26 and way above its 200-day moving average of $34.94.

LEAVE A REPLY

Please enter your comment!
Please enter your name here